Our assumption that EMMPRIN, VEGF, and MMP-9 contribute to the development of diabetic microvascular complications such as retinopathy is further supported by the evidence of elevated serum levels of EMMPRIN in diabetic patients [27,49]. The gene discussed is MMP9; the disease is retinal disorder.